- Home
- GAIN vs FLGT Comparison
GAIN vs FLGT Comparison
Compare GAIN & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAIN
- FLGT
- Stock Information
- Founded
- GAIN 2005
- FLGT 2011
- Country
- GAIN United States
- FLGT United States
- Employees
- GAIN N/A
- FLGT N/A
- Industry
- GAIN Finance: Consumer Services
- FLGT Medical Specialities
- Sector
- GAIN Finance
- FLGT Health Care
- Exchange
- GAIN Nasdaq
- FLGT Nasdaq
- Market Cap
- GAIN 522.8M
- FLGT 587.3M
- IPO Year
- GAIN 2005
- FLGT 2016
- Fundamental
- Price
- GAIN $14.15
- FLGT $22.17
- Analyst Decision
- GAIN Hold
- FLGT Buy
- Analyst Count
- GAIN 2
- FLGT 3
- Target Price
- GAIN $13.50
- FLGT $25.33
- AVG Volume (30 Days)
- GAIN 124.1K
- FLGT 257.8K
- Earning Date
- GAIN 08-12-2025
- FLGT 08-01-2025
- Dividend Yield
- GAIN 15.53%
- FLGT N/A
- EPS Growth
- GAIN 8.96
- FLGT N/A
- EPS
- GAIN 2.16
- FLGT N/A
- Revenue
- GAIN $95,028,000.00
- FLGT $303,223,000.00
- Revenue This Year
- GAIN $6.70
- FLGT $15.19
- Revenue Next Year
- GAIN $5.50
- FLGT $10.58
- P/E Ratio
- GAIN $6.55
- FLGT N/A
- Revenue Growth
- GAIN 6.55
- FLGT 4.31
- 52 Week Low
- GAIN $11.42
- FLGT $14.57
- 52 Week High
- GAIN $15.34
- FLGT $23.56
- Technical
- Relative Strength Index (RSI)
- GAIN 53.10
- FLGT 67.71
- Support Level
- GAIN $13.92
- FLGT $21.27
- Resistance Level
- GAIN $14.17
- FLGT $21.77
- Average True Range (ATR)
- GAIN 0.18
- FLGT 0.59
- MACD
- GAIN -0.01
- FLGT 0.04
- Stochastic Oscillator
- GAIN 41.54
- FLGT 91.35
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.